To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene HVCN1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
165 supporting clones for gene HVCN1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AK293543 cerebellum .a 1 to 1215 1 to 1215 F203Y tiling clone,   1215/1215
(100 %)
1 diff
(100.0 %id)
DC303408 cerebellum .a 1 to 577 1 to 577       577/577
(100 %)
0 diff
(100 %id)
DB053380 testis .b 1 to 570 2 to 571   tiling clone, capped   570/570
(100 %)
0 diff
(100 %id)
BM466354 embryonal carcinoma, cell line, testis .b 548 to 1030 18 to 502       485/1266
(38 %)
16 diff
(98.8 %id)
BC032672 Testis, embryonal carcinoma .b 550 to 2729 1 to 2181 exact tiling clone, available from MGC, AAA   2181/2181
(100 %)
1 diff
(100.0 %id)
AA251601 germinal center B cell .b 2114 to 2292 1 to 179       179/179
(100 %)
0 diff
(100 %id)
FN055064 breast carcinoma .b 2168 to 2266 1 to 99       99/103
(96 %)
2 diff
(98.1 %id)
AI433364 lymph node, lymphoma, follicular mixed small and largecell .b 2186 to 2494 309 to 1       309/309
(100 %)
0 diff
(100 %id)
DB338734 testis .b 2192 to 2734 544 to 1       544/544
(100 %)
2 diff
(99.7 %id)
DB451519.
matches multiple genes
testis .c 1 to 499 1 to 499   tiling clone, also hits gene TCTN1 499/499
(100 %)
2 diff
(99.6 %id)
DB461860.
matches multiple genes
testis .c 1 to 354 1 to 355     also hits gene TCTN1 355/355
(100 %)
4 diff
(98.9 %id)
NM_032369.2   .c 1 to 1711 1 to 1711 exact RefSeq,   1711/1711
(100 %)
0 diff
(100 %id)
DC306019 cerebellum .c 10 to 511 1 to 502       502/502
(100 %)
2 diff
(99.7 %id)
BI831671 brain, medulla .c 14 to 817 1 to 811       811/812
(99 %)
22 diff
(97.3 %id)
TI_57175549   .c 14 to 817 68 to 878       811/879
(92 %)
30 diff
(96.6 %id)
DC338915 subthalamic nucleus .c 18 to 581 1 to 564       564/564
(100 %)
0 diff
(100 %id)
BX489033   .c 26 to 617 1 to 592       592/592
(100 %)
5 diff
(99.2 %id)
DC338337 subthalamic nucleus .c 27 to 590 1 to 565       565/565
(100 %)
1 diff
(99.9 %id)
DT218289 brain .c 27 to 735 1 to 709       709/709
(100 %)
0 diff
(100 %id)
BP302106   .c 27 to 604 1 to 578       578/581
(99 %)
7 diff
(98.8 %id)
BP306785   .c 27 to 606 1 to 580       580/580
(100 %)
2 diff
(99.7 %id)
BG720071 testis .c 28 to 754 1 to 727       727/731
(99 %)
5 diff
(99.4 %id)
BP340417 Spleen .c 28 to 607 1 to 580       580/580
(100 %)
0 diff
(100 %id)
BP298014   .c 29 to 578 1 to 550       550/550
(100 %)
10 diff
(98.2 %id)
BC009731 Lung, large cell carcinoma .c 34 to 1617 1 to 1584 exact tiling clone, available from MGC, AAA   1584/1584
(100 %)
0 diff
(100 %id)
BF342683 brain, glioblastoma with EGFR amplification .c 35 to 563 5 to 537       533/537
(99 %)
18 diff
(96.7 %id)
BM926724 pooled lung and spleen .c 35 to 1070 10 to 1042 A240R K241Q I242N E253G E255K ...     1036/1110
(93 %)
15 diff
(98.7 %id)
TI_57167735   .c 35 to 807 65 to 841       777/892
(87 %)
34 diff
(96.2 %id)
BG759469 B-cells, primary B-cells from tonsils (cell line) .c 40 to 778 1 to 741       741/741
(100 %)
7 diff
(99.1 %id)
CN261579 embryonic stem cells, cell lines H1, H7, andH9 .c 41 to 774 1 to 735       735/735
(100 %)
3 diff
(99.6 %id)
BI834554 pooled pancreas and spleen .c 41 to 807 1 to 771       771/822
(93 %)
28 diff
(96.6 %id)
BG340708 B-cells, primary B-cells from tonsils (cell line) .c 42 to 794 1 to 748       748/748
(100 %)
14 diff
(98.2 %id)
CX872469 embryonic stem .c 42 to 767 1 to 726       726/726
(100 %)
0 diff
(100 %id)
NM_001040107.1   .d 1 to 1736 1 to 1736 exact RefSeq,   1736/1736
(100 %)
0 diff
(100 %id)
BP375483 uterus .d 1 to 561 1 to 561   tiling clone,   561/561
(100 %)
0 diff
(100 %id)
DC354717 lung .d 4 to 585 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BQ227004 large cell carcinoma, lung .d 48 to 790 1 to 749       749/833
(89 %)
12 diff
(98.6 %id)
BG436646 large cell carcinoma, lung .d 49 to 445 1 to 399       399/888
(44 %)
9 diff
(99.0 %id)
BU899218 Spleen .d 52 to 834 1 to 785       785/887
(88 %)
5 diff
(99.5 %id)
BQ712125 Spleen .d 52 to 602 1 to 555       555/996
(55 %)
9 diff
(99.1 %id)
BQ706093 Spleen .d 52 to 655 1 to 607       605/980
(61 %)
12 diff
(98.8 %id)
DC396748 testis .d 55 to 604 1 to 550       550/555
(99 %)
2 diff
(99.7 %id)
AA311897   .d 58 to 320 1 to 262       262/262
(100 %)
2 diff
(99.3 %id)
TI_57178100   .d 60 to 877 27 to 845       819/1010
(81 %)
14 diff
(98.7 %id)
CN261578 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 63 to 748 10 to 695       686/695
(98 %)
6 diff
(99.2 %id)
BQ421787 large cell carcinoma, lung .d 63 to 834 9 to 788       780/870
(89 %)
20 diff
(97.8 %id)
BI770180 pooled lung and spleen .d 64 to 877 1 to 815       815/980
(83 %)
9 diff
(99.1 %id)
CR596429 Placenta Cot 25-normalized .d 66 to 1590 1 to 1525 exact tiling clone,   1525/1525
(100 %)
0 diff
(100 %id)
AL545867 placenta, Placenta Cot 25-normalized .d 66 to 888 1 to 822   fully sequenced,   822/822
(100 %)
6 diff
(99.3 %id)
CN261577 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 69 to 602 1 to 534       534/534
(100 %)
0 diff
(100 %id)
BM543473 brain, hippocampus .d 71 to 956 1 to 902       902/1009
(89 %)
30 diff
(97.1 %id)
TI_1948102311   .d 182 to 908 123 to 854   fully sequenced,   732/854
(85 %)
9 diff
(99.0 %id)
TI_1948102649   .d 182 to 632 121 to 571   fully sequenced,   451/571
(78 %)
5 diff
(99.2 %id)
TI_1948102811   .d 182 to 632 119 to 570   fully sequenced,   452/570
(79 %)
6 diff
(99.0 %id)
GU211002   .d 191 to 1012 1 to 822 M91T     822/822
(100 %)
3 diff
(99.7 %id)
TI_1948102650   .d 571 to 1011 567 to 127   fully sequenced,   441/567
(77 %)
0 diff
(100 %id)
TI_1948102812   .d 571 to 1011 564 to 124   fully sequenced,   441/564
(78 %)
0 diff
(100 %id)
AL571425 placenta, Placenta Cot 25-normalized .d 858 to 1568 732 to 21   fully sequenced,   712/732
(97 %)
4 diff
(99.5 %id)
TI_1948102312   .d 878 to 1011 256 to 124   fully sequenced,   133/160
(83 %)
0 diff
(100 %id)
BQ020897 lung, Metastatic Chondrosarcoma .d 1003 to 1642 659 to 19   AAA   641/641
(100 %)
3 diff
(99.6 %id)
AW406569 lymph .d 1023 to 1641 8 to 626       619/626
(98 %)
6 diff
(99.1 %id)
TI_154144202   .d 1023 to 1641 80 to 698       619/623
(99 %)
1 diff
(99.9 %id)
AI936701 anaplastic oligodendroglioma, brain .d 1140 to 1642 503 to 1       503/503
(100 %)
0 diff
(100 %id)
AI288290 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .d 1149 to 1643 518 to 26       493/518
(95 %)
0 diff
(100 %id)
AA807519 germinal center B cell .d 1182 to 1642 482 to 22   AAA   461/461
(100 %)
0 diff
(100 %id)
AA831648 germinal center B cell .d 1192 to 1642 469 to 19   AAA   451/451
(100 %)
0 diff
(100 %id)
AA811096 germinal center B cell .d 1197 to 1642 456 to 11   AAA   446/446
(100 %)
1 diff
(99.8 %id)
AA995833 germ cell tumor .d 1213 to 1643 430 to 1       430/430
(100 %)
2 diff
(99.6 %id)
AI399974 B-cell, chronic lymphotic leukemia .d 1215 to 1641 428 to 2       427/428
(99 %)
0 diff
(100 %id)
AW296987   .d 1222 to 1642 438 to 18   AAA   421/421
(100 %)
1 diff
(99.8 %id)
AA620934   .d 1224 to 1642 419 to 1       419/419
(100 %)
4 diff
(99.1 %id)
AA255934 germinal center B cell .d 1236 to 1642 407 to 1       407/407
(100 %)
5 diff
(98.8 %id)
AI125257   .d 1267 to 1643 378 to 3       376/378
(99 %)
0 diff
(100 %id)
BF941832 fibrotheoma, ovary .d 1289 to 1643 355 to 1   tiling clone,   355/355
(100 %)
0 diff
(100 %id)
AI624251 adenocarcinoma, Pancreas .d 1298 to 1642 345 to 1       345/345
(100 %)
0 diff
(100 %id)
TI_57179479   .d 1305 to 1642 28 to 364   AAA   337/364
(92 %)
6 diff
(98.4 %id)
BI769676 pooled lung and spleen .d 1307 to 1642 1 to 335   AAA   335/335
(100 %)
1 diff
(99.8 %id)
AI865144 lymph node, lymphoma, follicular mixed small and largecell .d 1327 to 1641 316 to 2       315/316
(99 %)
0 diff
(100 %id)
AW418839 2 pooled tumors (clear cell type), Kidney .d 1340 to 1640 305 to 5       301/305
(98 %)
0 diff
(100 %id)
AA258869 germinal center B cell .d 1349 to 1642 315 to 22   AAA   294/294
(100 %)
1 diff
(99.7 %id)
BU957917 mixed (pool of 40 RNAs) .d 1349 to 1634 1 to 286       286/326
(87 %)
4 diff
(98.8 %id)
CD517901 White Matter .e 1 to 769 1 to 773 K233* tiling clone,   773/917
(84 %)
8 diff
(99.2 %id)
DC354564 Kidney .f 1 to 572 1 to 572   tiling clone,   572/572
(100 %)
2 diff
(99.7 %id)
BQ710309 Spleen .f 8 to 816 2 to 816       815/947
(86 %)
20 diff
(97.9 %id)
BQ707764 Spleen .f 18 to 852 1 to 845       845/926
(91 %)
23 diff
(97.6 %id)
AY359054   .f 23 to 1323 1 to 1301 E164S F165S H167T H168T K169S ... tiling clone, AAA   1301/1301
(100 %)
3 diff
(99.8 %id)
BP208898 cerebellum .f 31 to 611 1 to 580       580/582
(99 %)
3 diff
(99.5 %id)
DC380247 placenta .f 31 to 583 1 to 553       553/553
(100 %)
0 diff
(100 %id)
TI_154188379   .f 37 to 983 123 to 1060       940/938
(100 %)
19 diff
(98.0 %id)
BE786173 large cell carcinoma, lung .f 128 to 874 8 to 757       750/779
(96 %)
35 diff
(95.6 %id)
BQ939625 large cell carcinoma, lung .f 128 to 769 7 to 649       643/954
(67 %)
17 diff
(98.3 %id)
CV025403 mixed .f 232 to 874 1 to 643       643/650
(98 %)
2 diff
(99.7 %id)
BX391867   .f 251 to 875 623 to 1       623/623
(100 %)
4 diff
(99.4 %id)
BG686083 B-cells, primary B-cells from tonsils (cell line) .f 251 to 988 11 to 747       740/754
(98 %)
20 diff
(97.4 %id)
BG757499 B-cells, primary B-cells from tonsils (cell line) .f 251 to 959 11 to 717   tiling clone,   710/718
(98 %)
7 diff
(99.1 %id)
BM564174 blood, natural killer cells, cell line .f 255 to 995 1 to 741       741/1108
(66 %)
12 diff
(99.0 %id)
BE790209 large cell carcinoma, lung .f 281 to 875 1 to 593       593/596
(99 %)
5 diff
(99.2 %id)
FN171829 breast carcinoma .f 747 to 840 94 to 1     Submitted on the opposite strand 94/94
(100 %)
0 diff
(100 %id)
BU595990 mixed (pool of 40 RNAs) .g 1 to 757 1 to 761   tiling clone,   761/788
(96 %)
14 diff
(98.3 %id)
BI261820 lymph, lymphoma, cell line .g 70 to 731 1 to 661       661/661
(100 %)
4 diff
(99.4 %id)
BQ643409 lymph, lymphoma, cell line .g 72 to 1047 1 to 987 Y22C K212X Q217P L239P N240Y     987/994
(99 %)
30 diff
(97.0 %id)
BQ052657 blood, natural killer cells, cell line .g 130 to 1021 1 to 893 E235X E251* tiling clone,   893/1033
(86 %)
12 diff
(98.9 %id)
BM476403 lymph, lymphoma, cell line .g 149 to 1097 1 to 965 E235X tiling clone,   965/970
(99 %)
25 diff
(97.5 %id)
BF976109 B-cells, primary B-cells from tonsils (cell line) .g 255 to 1040 1 to 784       784/791
(99 %)
24 diff
(97.0 %id)
BI262491 lymph, lymphoma, cell line .g 968 to 1486 542 to 24   tiling clone,   519/542
(95 %)
0 diff
(100 %id)
BQ069060 brain, neuroblastoma, cell line .h 1 to 962 1 to 970 V209X A210G R211P I212D I213H ... tiling clone,   970/1031
(94 %)
15 diff
(98.6 %id)
BE258655 eye, retinoblastoma .i 1 to 627 33 to 658   tiling clone,   626/658
(95 %)
6 diff
(99.1 %id)
BC007277 Eye, retinoblastoma .i 2 to 2086 1 to 2085 exact tiling clone, available from MGC, AAA   2085/2085
(100 %)
0 diff
(100 %id)
TI_1948237423   .i 737 to 1455 129 to 849       719/1245
(57 %)
18 diff
(98.6 %id)
TI_1948237424   .i 737 to 1459 128 to 851 E188D S211G Q217P E220*     724/1240
(58 %)
16 diff
(98.8 %id)
TI_1948237647   .i 737 to 1392 128 to 789       662/1377
(48 %)
24 diff
(98.3 %id)
TI_1948237648   .i 737 to 974 129 to 366       238/257
(92 %)
5 diff
(98.1 %id)
TI_1948237873   .i 737 to 1455 131 to 852       722/1273
(56 %)
17 diff
(98.7 %id)
TI_1948237874   .i 737 to 1455 124 to 842       719/1263
(56 %)
13 diff
(99.0 %id)
TI_1948238106   .i 737 to 1397 129 to 797       669/1307
(51 %)
21 diff
(98.4 %id)
TI_1948238107   .i 737 to 1370 126 to 769       644/1382
(46 %)
28 diff
(98.0 %id)
EL733329 mixed .i 746 to 1362 1 to 613       613/620
(98 %)
6 diff
(99.1 %id)
BQ233898 large cell carcinoma, lung .i 886 to 1758 1 to 875       875/876
(99 %)
10 diff
(98.9 %id)
TI_1948237425   .i 939 to 1455 641 to 123       519/1348
(38 %)
6 diff
(99.6 %id)
BX400008   .i 1065 to 2055 987 to 1       987/987
(100 %)
8 diff
(99.2 %id)
TI_1948237875   .i 1101 to 1455 479 to 125       355/382
(92 %)
0 diff
(100 %id)
TI_1948237650   .i 1108 to 1455 471 to 124       348/375
(92 %)
0 diff
(100 %id)
TI_1948238108   .i 1127 to 1455 453 to 125       329/356
(92 %)
0 diff
(100 %id)
BF337501 brain, glioblastoma with EGFR amplification .i 1129 to 1803 13 to 693       681/934
(72 %)
20 diff
(97.9 %id)
CB162302 Liver .i 1164 to 1797 1 to 634       634/634
(100 %)
1 diff
(99.9 %id)
TI_1948237426   .i 1194 to 1455 386 to 125       262/289
(90 %)
0 diff
(100 %id)
BG756422 B-cells, primary B-cells from tonsils (cell line) .i 1206 to 2010 1 to 806       806/806
(100 %)
7 diff
(99.2 %id)
BI834245 pooled pancreas and spleen .i 1214 to 2078 1 to 864       864/926
(93 %)
10 diff
(99.0 %id)
TI_57163706   .i 1214 to 2078 31 to 894   AAA   864/947
(91 %)
16 diff
(98.4 %id)
AU185046 skin .i 1251 to 1823 576 to 3       574/578
(99 %)
7 diff
(98.8 %id)
BQ336205 marrow .i 1282 to 1474 12 to 197       186/197
(94 %)
8 diff
(96.0 %id)
BF840714 head_neck .i 1292 to 1797 3 to 501       499/501
(99 %)
15 diff
(97.1 %id)
W94991 liver and spleen .i 1310 to 1854 1 to 546   fully sequenced,   546/546
(100 %)
7 diff
(98.8 %id)
CB049045 Prostate .i 1310 to 1571 10 to 271   fully sequenced,   262/271
(96 %)
6 diff
(97.8 %id)
AW968083   .i 1339 to 1738 24 to 425       402/425
(94 %)
13 diff
(97.0 %id)
AW968081   .i 1348 to 2009 1 to 663       663/663
(100 %)
12 diff
(98.2 %id)
AI819639 lymph node, lymphoma, follicular mixed small and largecell .i 1351 to 1826 476 to 1       476/476
(100 %)
0 diff
(100 %id)
AI439493 lymph node, lymphoma, follicular mixed small and largecell .i 1352 to 1826 475 to 1       475/475
(100 %)
0 diff
(100 %id)
BX103110 liver and spleen .i 1358 to 1826 1 to 469   AAA   469/469
(100 %)
0 diff
(100 %id)
BE784330 large cell carcinoma, lung .i 1377 to 2022 1 to 651       651/694
(93 %)
15 diff
(97.9 %id)
BE784703 large cell carcinoma, lung .i 1378 to 1930 1 to 576       543/577
(94 %)
24 diff
(95.9 %id)
AI364713 B-cell, chronic lymphotic leukemia .i 1389 to 1826 438 to 1       438/438
(100 %)
0 diff
(100 %id)
BG757629 B-cells, primary B-cells from tonsils (cell line) .i 1394 to 2061 1 to 671       671/742
(90 %)
12 diff
(98.4 %id)
BM709214 eye, optic nerve .i 1409 to 1964 1 to 556       556/556
(100 %)
0 diff
(100 %id)
BM998357 lung, Metastatic Chondrosarcoma .i 1490 to 2086 615 to 19   AAA   597/609
(98 %)
14 diff
(97.8 %id)
W93376 liver and spleen .i 1505 to 1857 355 to 1   fully sequenced,   355/355
(100 %)
4 diff
(98.9 %id)
CB049044 Prostate .i 1541 to 2061 544 to 24   fully sequenced, AAA   521/521
(100 %)
0 diff
(100 %id)
BP302710   .i 1588 to 2061 1 to 474   AAA   474/474
(100 %)
2 diff
(99.6 %id)
AI092616 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .i 1634 to 2062 429 to 1       429/438
(97 %)
1 diff
(99.8 %id)
AA902810 pooled germ cell tumors .i 1659 to 2060 402 to 1       402/402
(100 %)
0 diff
(100 %id)
AI051856   .i 1661 to 2065 407 to 4       404/407
(99 %)
0 diff
(100 %id)
AI633736 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .i 1667 to 2060 396 to 3       394/396
(99 %)
0 diff
(100 %id)
CN261576 embryonic stem cells, DMSO-treated H9 cellline .i 1671 to 2069 1 to 399       399/401
(99 %)
6 diff
(98.6 %id)
CD672803 eye, Iris .i 1682 to 2061 1 to 380   AAA   380/380
(100 %)
0 diff
(100 %id)
AW075771 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood .i 1831 to 2061 231 to 1       231/231
(100 %)
0 diff
(100 %id)
BG490508 large cell carcinoma, lung .j 1 to 695 1 to 696 P87T L120W F187L K197E F198V ... tiling clone,   696/699
(99 %)
11 diff
(98.5 %id)
BI825974 brain, medulla .k 1 to 816 1 to 814 exact tiling clone,   814/814
(100 %)
6 diff
(99.3 %id)
TI_57173818   .k 1 to 816 32 to 845 exact     814/845
(96 %)
10 diff
(98.9 %id)
DC397693 testis .l 1 to 575 1 to 577 exact tiling clone,   577/577
(100 %)
2 diff
(99.7 %id)
DC399719 testis .m 1 to 483 1 to 483 R44W tiling clone,   483/483
(100 %)
1 diff
(99.8 %id)
DC397842 testis .m 65 to 606 1 to 547   tiling clone,   547/547
(100 %)
5 diff
(99.1 %id)
BG718651 testis .n 1 to 693 8 to 698 P24H H25T Q26S S27L Q28R ... tiling clone,   691/699
(98 %)
9 diff
(98.8 %id)
BX644696   .o 1 to 789 1 to 788 exact tiling clone,   788/788
(100 %)
8 diff
(99.0 %id)
DC399559 testis .p 1 to 536 4 to 539 exact tiling clone,   539/539
(100 %)
0 diff
(100 %id)
BE147329 head_neck .q 1 to 269 57 to 325 D2C L6R T7S N16D tiling clone,   269/331
(81 %)
10 diff
(97.0 %id)
DB518361.
matches multiple genes
testis Gene TCTN1, variant not shown         Suspected internal deletion, this clone was ignored, also hits gene TCTN1    
DB518361.
matches multiple genes
testis Gene HVCN1, variant not shown         Suspected internal deletion, this clone was ignored, also hits gene TCTN1    
DB452903.
matches multiple genes
testis Gene TCTN1, variant not shown         Suspected internal deletion, this clone was ignored, also hits gene TCTN1    
DB452903.
matches multiple genes
testis Gene HVCN1, variant not shown         Suspected internal deletion, this clone was ignored, also hits gene TCTN1    
BP208308 cerebellum Gene HVCN1, variant not shown         Suspected internal deletion, this clone was ignored    
BP369986 testis Gene HVCN1, variant not shown         Suspected internal deletion, this clone was ignored    
BG772095 testis Gene HVCN1, variant not shown         This clone was ignored    
BE787139 large cell carcinoma, lung Gene HVCN1, variant not shown         Suspected internal deletion, this clone was ignored    
BU959497 mixed (pool of 40 RNAs) Gene HVCN1, variant not shown         Suspected internal deletion, this clone was ignored    
DC396831 testis Gene HVCN1, variant not shown         Suspected internal deletion, this clone was ignored    
DB084500 testis Gene HVCN1, variant not shown       capped This clone was ignored    
DB341044 testis Gene HVCN1, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C